View More Recent Stories
-
JMP Securities Reiterates Market Outperform Rating on Zimmer Biomet (ZBH)
-
Zimmer Biomet (ZBH) PT Lowered to $122 at BTIG
-
Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 1c, guides below consensus
-
BTIG Reiterates Buy Rating on Zimmer Biomet (ZBH)
-
JMP Securities reports on Paragon 28 acquisition by Zimmer Biomet
-
Zimmer Biomet Holdings (ZBH) to Acquire Paragon 28 for $1.1 bln
-
Zimmer Biomet (ZBH) PT Raised to $138 at Stifel
-
Zimmer Biomet Holdings (ZBH) Declares $0.24 Quarterly Dividend; 0.9% Yield
-
JPMorgan Upgrades Zimmer Biomet (ZBH) to Overweight
-
Zimmer Biomet Holdings (ZBH) Receives FDA Clearance for OsseoFit Stemless Shoulder System for Total Shoulder Replacement
-
Zimmer Biomet Holdings (ZBH) Receives FDA Clearance for Persona SoluTion PPS® Femur
-
Zimmer Biomet Holdings (ZBH) Receives FDA Approval for Oxford Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.
-
Barclays highlights most and least sensitive MedTech stocks to changes in surgical volumes
-
Zimmer Biomet (ZBH) Announces CE Mark Certification for Persona® Revision Knee System
-
Zimmer Biomet Holdings (ZBH) Appoints Arnold Schwarzenegger as Chief Movement Officer
-
Zimmer Biomet (ZBH) PT Raised to $117 at Truist Securities
-
Oppenheimer Reiterates Outperform Rating on Zimmer Biomet (ZBH)
-
Zimmer Biomet Holdings (ZBH) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY24 EPS Guidance
-
Zimmer Biomet Holdings (ZBH) to Debut New Z1 Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting
-
Vague Midwest Boutique Channel-Check Firm Comments Circulate Via Traders on Three Stocks
-
Zimmer Biomet (ZBH) PT Lowered to $135 at Oppenheimer
-
Zimmer Biomet (ZBH) PT Lowered to $126 at BTIG
-
FDA Alerts On Risk Of Fracture After Surgery with Zimmer Biomet (ZBH) System
-
Needham Reiterates Hold Rating on Zimmer Biomet (ZBH)
-
Zimmer Biomet (ZBH) PT Lowered to $112 at Truist Securities
-
Zimmer Biomet (ZBH) PT Lowered to $115 at Canaccord Genuity
-
Zimmer Biomet (ZBH) PT Lowered to $119 at TD Cowen
-
Increasing unusual option volume: ZBH FYBR APLD BMRN UNIT CASY HPP CPRT ZETA AVAV CHPT
-
Stifel Reiterates Buy Rating on Zimmer Biomet (ZBH), 'we wait to more-thoughtfully reflect on these ERP-related challenges'
-
Zimmer Biomet Holdings (ZBH)Declines Following Conf. Presentation, Down 5%
-
Zimmer Biomet (ZBH) PT Lowered to $120 at Canaccord Genuity
-
Increasing unusual put option volume: HUMA LUMN JBLU CHGG AX VSCO ZBH DOCS RILY MDT SYM STLA ILMN
-
Zimmer Biomet (ZBH) PT Lowered to $130 at Stifel
-
Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 2c, provides guidance
-
Zimmer Biomet Holdings (ZBH) to Acquire OrthoGrid Systems
-
Increasing unusual put volume: AVTR BHC ZBH CMG LW APLD TELL AES
-
Zimmer Biomet Holdings (ZBH) August 100 puts trade on the bid at $1
-
Zimmer Biomet Holdings (ZBH) Appoints Devdatt Kurdikar to its Board
-
RevelAi Health and Zimmer Biomet (ZBH) Announce Exclusive Multi-Year Co-Marketing Agreement to Advance Value-Based Care and Health Equity through AI-Powered Technology
-
Zimmer Biomet (ZBH) Enters Distribution Agreement with THINK Surgical to Offer TMINI Miniature Handheld Robotic System for Total Knee Arthroplasty
-
Analyst weighs in on current investor sentiment in MedTech sector

